MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ejhf.3082

Медицинская библиотека · European journal of heart failure · 2023

Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock.

Sundermeyer Jonas, Kellner Caroline, Beer Benedikt N, Besch Lisa, Dettling Angela, Bertoldi Letizia Fausta, Blankenberg Stefan, Dauw Jeroen, Dindane Zouhir, Eckner Dennis, Eitel Ingo, Graf Tobias, Horn Patrick, Jozwiak-Nozdrzykowska Joanna, Kirchhof Paulus, Kluge Stefan, Linke Axel, Landmesser Ulf, Luedike Peter, Lüsebrink Enzo, Majunke Nicolas, Mangner Norman, Maniuc Octavian, Möbius Winkler Sven, Nordbeck Peter, Orban Martin, Pappalardo Federico, Pauschinger Matthias, Pazdernik Michal, Proudfoot Alastair, Kelham Matthew, Rassaf Tienush, Reichenspurner Hermann, Scherer Clemens, Schulze Paul Christian, Schwinger Robert H G, Skurk Carsten, Sramko Marek, Tavazzi Guido, Thiele Holger, Villanova Luca, Morici Nuccia, Winzer Ephraim B, Westermann Dirk, Gustafsson Finn, Schrage Benedikt

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

AIMS: Heart failure-related cardiogenic shock (HF-CS) accounts for a significant proportion of CS cases. Whether patients with de novo HF and those with acute-on-chronic HF in CS differ in clinical characteristics and outcome remains unclear. The aim of this study was to evaluate differences in clinical presentation and mortality between patients with de novo and acute-on-chronic HF-CS.

METHODS AND

RESULTS

In this international observational study, patients with HF-CS from 16 tertiary care centres in five countries were enrolled between 2010 and 2021. To investigate differences in clinical presentation and 30-day mortality, adjusted logistic/Cox regression models were fitted. Patients (n = 1030) with HF-CS were analysed, of whom 486 (47.2%) presented with de novo HF-CS and 544 (52.8%) with acute-on-chronic HF-CS. Traditional markers of CS severity (e.g. blood pressure, heart rate and lactate) as well as use of treatments were comparable between groups. However, patients with acute-on-chronic HF-CS were more likely to have a higher CS severity and also a higher mortality risk, after adjusting for relevant confounders (de novo HF 45.5%, acute-on-chronic HF 55.9%, adjusted hazard ratio 1.38, 95% confidence interval 1.10-1.72, p = 0.005).

CONCLUSION

In this large HF-CS cohort, acute-on-chronic HF-CS was associated with more severe CS and higher mortality risk compared to de novo HF-CS, although traditional markers of CS severity and use of treatments were comparable. These findings highlight the vast heterogeneity of patients with HF-CS, emphasize that HF chronicity is a relevant disease modifier in CS, and indicate that future clinical trials should account for this.

Для цитирования: Sundermeyer Jonas, Kellner Caroline, Beer Benedikt N, Besch Lisa, Dettling Angela, Bertoldi Letizia Fausta, Blankenberg Stefan, Dauw Jeroen, Dindane Zouhir, Eckner Dennis, Eitel Ingo, Graf Tobias, Horn Patrick, Jozwiak-Nozdrzykowska Joanna, Kirchhof Paulus, Kluge Stefan, Linke Axel, Landmesser Ulf, Luedike Peter, Lüsebrink Enzo, Majunke Nicolas, Mangner Norman, Maniuc Octavian, Möbius Winkler Sven, Nordbeck Peter, Orban Martin, Pappalardo Federico, Pauschinger Matthias, Pazdernik Michal, Proudfoot Alastair, Kelham Matthew, Rassaf Tienush, Reichenspurner Hermann, Scherer Clemens, Schulze Paul Christian, Schwinger Robert H G, Skurk Carsten, Sramko Marek, Tavazzi Guido, Thiele Holger, Villanova Luca, Morici Nuccia, Winzer Ephraim B, Westermann Dirk, Gustafsson Finn, Schrage Benedikt. Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock.. European journal of heart failure. 2023. DOI: 10.1002/ejhf.3082.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.